These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8214294)

  • 21. Activation of the RAS/RAF/ERK signaling pathway contributes to resistance to sunitinib in thyroid carcinoma cell lines.
    Piscazzi A; Costantino E; Maddalena F; Natalicchio MI; Gerardi AM; Antonetti R; Cignarelli M; Landriscina M
    J Clin Endocrinol Metab; 2012 Jun; 97(6):E898-906. PubMed ID: 22442268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAX8-PPARgamma oncogene in follicular thyroid tumors: RT-PCR and immunohistochemical analyses.
    Pauzar B; Karner I; Glavas-Obrovac L; Stefanić M; Dmitrović B
    Coll Antropol; 2012 Nov; 36 Suppl 2():79-82. PubMed ID: 23397760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan.
    Liu RT; Hou CY; You HL; Huang CC; Hock-Liew ; Chou FF; Wang PW; Cheng JT
    Thyroid; 2004 Aug; 14(8):616-21. PubMed ID: 15320975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.
    Sakr HI; Chute DJ; Nasr C; Sturgis CD
    Diagn Pathol; 2017 Oct; 12(1):71. PubMed ID: 28974238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
    Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
    Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pathogenesis of follicular cell derived thyroid cancers.
    Parameswaran R; Brooks S; Sadler GP
    Int J Surg; 2010; 8(3):186-93. PubMed ID: 20097316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors.
    Gorgoulis V; Aninos D; Priftis C; Evagelopoulou C; Karameris A; Kanavaros P; Spandidos DA
    In Vivo; 1992; 6(3):291-6. PubMed ID: 1391697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytochemically detectable TGF-beta associated with malignancy in thyroid epithelial neoplasia.
    Jasani B; Wyllie FS; Wright PA; Lemoine NR; Williams ED; Wynford-Thomas D
    Growth Factors; 1990; 2(2-3):149-55. PubMed ID: 2187493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
    Branet F; Brousset P; Krajewski S; Schlaifer D; Selves J; Reed JC; Caron P
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2726-30. PubMed ID: 8675602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
    Schulten HJ; Salama S; Al-Ahmadi A; Al-Mansouri Z; Mirza Z; Al-Ghamdi K; Al-Hamour OA; Huwait E; Gari M; Al-Qahtani MH; Al-Maghrabi J
    Anticancer Res; 2013 Nov; 33(11):4779-84. PubMed ID: 24222113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human malignant thyroid tumors displayed reduced levels of transforming growth factor beta receptor type II messenger RNA and protein.
    Lazzereschi D; Ranieri A; Mincione G; Taccogna S; Nardi F; Colletta G
    Cancer Res; 1997 May; 57(10):2071-6. PubMed ID: 9158007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
    Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
    Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
    Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
    Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
    Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
    Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular crossroads in thyroid tumorigenesis. Molecular genetics of human thyroid neoplasms.
    Thomas G
    Hum Exp Toxicol; 1994 Oct; 13(10):717-8. PubMed ID: 7826689
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
    Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
    In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oncogenes and thyroid tumors].
    Lacroix L; Soria JC; Bidart JM; Schlumberger M
    Bull Cancer; 2005 Jan; 92(1):37-43. PubMed ID: 15689324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
    Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop.
    Vieira JM; Santos SC; Espadinha C; Correia I; Vag T; Casalou C; Cavaco BM; Catarino AL; Dias S; Leite V
    Eur J Endocrinol; 2005 Nov; 153(5):701-9. PubMed ID: 16260429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.